| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.009 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.009 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.009 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |